Effects of suplatast tosilate (IPD Capsules®) on the production of active oxygen by neutrophils and of IL-8 by mononuclear cells

International Immunopharmacology

Volumn 1, Issue 6, 2001, Pages 1183-1187

  Tohda, Yuji ^a   Kubo, Hirokazu ^a   Haraguchi, Ryuta ^a   Iwanaga, Takashi ^a   Fukuoka, Masahiro ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Active oxygen species; Bronchial asthma; IL 8; Mononuclear cells; Neutrophils; Suplatast tosilate

Indexed keywords

ANTIALLERGIC AGENT; FORMYLMETHIONYLLEUCYLPHENYLALANINE; IMMUNOMODULATING AGENT; INTERLEUKIN 8; LUMINOL; OXYGEN; SUPLATAST TOSYLATE;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; LUNG EMPHYSEMA; LUNG FIBROSIS; MONONUCLEAR CELL; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM;

ADJUVANTS, IMMUNOLOGIC; ANTI-ALLERGIC AGENTS; ARYLSULFONATES; HUMANS; INTERLEUKIN-8; MONOCYTES; NEUTROPHILS; REACTIVE OXYGEN SPECIES; SULFONIUM COMPOUNDS;

EID: 0035035292     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(01)00053-4     Document Type: Article

References (23)

1. Teran L.M., Carroll M.P., Frew A.J., Rendington A.E., Davies D.F., Lindeley I.et al. Leukocyte recruitment after local endobronchial allergen challenge in asthma: relation to procedure and airway. Am. J. Respir. Crit. Care Med. 154:1996;469-476.
2. Nagata M., Sedgwick J.B., Kita H., Busse W.W. Granulocyte macrophage colony-stimulating factor augments ICAM-1 and VCAM-1 activation of eosinophil function. Am. J. Respir. Crit. Care Med. 19:1998;158-166.
3. Lamlin C., Gosset P., Tillie-Leblond I., Saulnier F., Marquette C.B.et al. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am. J. Respir. Crit. Care Med. 157:1998;394-402.
4. Nocker R.E., Schoonbrood D.F., van de Graaf E.A. Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int. Arch. Allergy Immunol. 109:1996;183-191.
5. Yousefi S., Hemmann S., Weber M.et al. IL-8 is expressed by human, peripheral blood eosinophils: evidence for increased secretion in asthma. J. Immunol. 154:1995;5481-5490.
6. Smart S.J., Casale T.B. Interleukin-8-induced transcellular neutrophil migration is facilitated by endothelial and pulmonary epithelial cells. Am. J. Respir. Cell Mol. Biol. 9:1993;489-495.
7. Erger R.A., Casale T.B. Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium. Am. J. Physiol. 268:1995;L117-L122.
8. Bittleman D.B., Erger R.A., Casale T.B. Cytokines induce selective granulocyte chemotactic responses. Inflammation Res. 45:1996;89-95.
9. Cassatella M.A., Bazzoni F., Ceska M., Ferro I., Baggiolini M.et al. IL-8 production by human polymorphonuclear leukocytes: the chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. J. Immunol. 148:1992;3216-3220.
10. Buckley M.G., Williams W.M., Thompson J.et al. IL-4 enhances IL-3 and IL-8 gene expression in a human leukemic mast cell line. Immunology. 84:1995;410-415.
11. Moeller A., Lippert U., Lessmannn D., Kolde G., Hamann K., Welker P.et al. Human mast cells produce IL-8. Immunology. 151:1993;3261-3266.
12. Johnston S.L. Natural and experimental rhinovirus infections of the lower respiratory tract. Am. J. Respir. Crit. Care Med. 152:1995;S46-S52.
13. Yanagihara Y., Kiniwa M., Ikizawa K., Shida T., Matsuura N., Koda A. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsufonium agent: (2) Regulation of human IgE response. Jpn. J. Pharmacol. 61:1993;31-39.
14. Yamaya H., Basaki Y., Kojima M., Kiniwa M., Matsuura M. Life Sci. 56(19):1993;1647-1654.
15. Shim J.J., Dabbagh K., Takeyama K.M., Burgel P., Dao-pick T.P., Ueki I.F.et al. Suplatast tosilate inhibits goblet-cell mataplasia of airway epithelium in sensitized mice. J. Allergy Clin. Immunol. 105:2000;739-745.
16. Miyamaoto M., Tanaka A., Yokoe A., Agachi M. Effect of suplatast tosilate (IPD-11521T) on cytokine production by allergen specific human Th1 and Th2 cell lines. Life Sci. 65(8):1999;763-770.
17. Kimata H. Selective enhancement of production of IgE, IgG4 and Th-2 cell cytokine during the rebound phenomenon in atopic dermatitis and revention by suplatast tosilate. Ann. Allergy, Asthma, Immunol. 82(3):1999;293-295.
18. Zhao G.D., Yokoyama A., Kohna N., Hamada H., Hiwada K. Effect of suplatast tosilate (IPD1151T) on a mouse model of asthma: inhibition of eosinophilic and bronchial hyperresponsiveness. Int. Arch. Allergy Immunol. 121(2):2000;116-122.
19. Fujiwara T. Fundamental and clinical studies of the immunomodulator antiallergic agent suplatast tosilate (IPD® Capsules) specifically inhibiting IgE antibody production. New Rem. Clin. 45:1996;65-83.
20. Tohda Y., Kubo H., Nakajima S. Effect of ONO-1078 on cytokine production in oerioheral blood mononuclear cells of patients with bronchial asthma. Clin. Exp. Allergy. 29(11):1999;1532-1536.
21. Iwanaga T., Tohda Y., Uejima H., Nagasaka Y., Nakajima S. Effect of cytokines on oxygen radical production by peripheral blood monocytes and alveolar macrophages in patients with asthma. Tumori. 84(4):1996;285-382.
22. Broide D.H., Lotz M., Cuomo A.J., Fedrman E.C., Wasserman S.I. Cytokines in symptomatic asthma airway. J. Allergy Clin. Immunol. 89:1992;958-967.
23. Marini M., Vittori E., Hollemborg J., Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J. Allergy Clin. Immunol. 89:1992;1001-1009.